New Tools Developed by Vitalea Science for Pediatric Pharmacology Use Microdose and Accelerator Mass Spectrometry

Thursday, 15 Feb 2007 · Biotechnology

Vitalea Science announces the development and testing of assays to quantify intracellular uptake and DNA incorporation of the active metabolite of an anti-HIV drug that can be applied to children and neonates. (PRWeb Feb 15, 2007) Post Comment:Trackback URL: http://www.prweb.com/zingpr.php/SGFsZi1FbXB0LUhhbGYtSG9yci1NYWduLVplcm8= Read More »

Also:

Vitalea Science Announces Key Addition to its Scientific Advisory Board in Microdosing for Pediatric Pharmacology and HIV Research
Vitalea Science Expands its Scientific Advisory Board, Expands Microdosing to Environmental Fate and Metabolism of Agricultural and Industrial Chemicals
ACD/Labs Announces LC/MS Project Management Software for Chromatographic Method Development
Related Fragment Screening: Swift and Easy Elucidation of Drug Metabolites
PREMIER Biosoft International Releases SimGlycan, an Innovative Glycan Mass Fingerprinting Tool

del.icio.us · digg it · link

	Vitalea Science Expands its Scientific Advisory Board, Expands Microdosing to Environmental Fate and Metabolism of Agricultural and Industrial Chemicals
	Technology Transfer Firm Partners with Local Alternative Energy Venture to Speed Commercialization: Innovation Management Partners, LLC Invests in Cleveland-based CleanFlo Technologies, LLC to Accelerate Technology Commercialization in the Growth Market for Alternative Fuels
	The AEgis Technologies Group Announces the Release of the Microsoft Excel Add-in for acslXtreme
	Monebo Technologies Obtains FDA Clearance to Market the CardioBeltâ„¢ Wireless ECG System
	Five Japanese Pharmaceutical Companies License Ariadne Pathway Studio Enterprise
	Alaska's Natural/Wild Food, Beverage and Bio Products Join Together to Stage Marketplace for Restaurant, Grocery and Food Service Market Buyers
	Akaza Research, SemanticBits and Robert H. Lurie Comprehensive Cancer Center of Northwestern University Partner to Develop caBIGâ„¢ Clinical Trials Adverse Events Reporting System for NIH's National Cancer Institute
	Amorcyte Cardiac Cell Therapy Trial Completes Second of Four Phases
	Vitalea Science Announces Key Addition to its Scientific Advisory Board in Microdosing for Pediatric Pharmacology and HIV Research
	Arrowhead Publishers' New Study Reveals Trends in Pharmaceutical Clinical Trial Outsourcing to Emerging Markets

	Biotechnology
	Electronics
	General
	Graphic Design & Printing
	Industrial
	Information Technology
	Instrumentation
	Multimedia
	Nanotechnology
	Public Sector
	Robotics
	Semiconductors
	Telecommunications